Despite the recent upturn, the company’s financial performan...
Despite the recent upturn, the company’s financial performance is seen as too risky due to its sustained revenue decline and loss-making status.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4110Followers
0Following
9126Visitors
Follow
MikeyMikeMike : Most all small cap pharma stock has issues with revenue. It's the cost of research and development that smaller companies have to sustain that causes this.